FIELD: pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics and concerns a composition for treating oral candidiasis and a method of treating candidiasis with using it. Disclosed composition contains: 2-((1S,2S,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)sulphanylethanol – 1 wt.%, emulsifier Tween-80 – 1.22 wt.%, distilled water – up to 100 wt.%. A method of treating oral candidiasis with the above composition consists in the fact that composition 0.5 ml is taken and the oral mucosa is completely wetted 2 times a day.
EFFECT: wider range of tools for the specified purpose.
2 cl, 4 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING ORAL CANDIDIASIS | 2021 |
|
RU2780094C1 |
METHOD OF TREATING ORAL CANDIDIASIS IN POSTCOVID PATIENTS | 2024 |
|
RU2837138C1 |
METHOD FOR TREATING CHRONIC ATROPHIC CANDIDOSIS OF ORAL MUCOSA IN PATIENTS WITH CHRONIC BILIARY-DEPENDENT PANCREATITIS | 2023 |
|
RU2812661C1 |
METHOD OF TREATING CANDIDIASIS OF ORAL MUCOSA | 2023 |
|
RU2812033C1 |
METHOD OF DIAGNOSTICS OF CANDIDIASIS OF UPPER RESPIRATORY TRACT IN WORKERS OF AGROINDUSTRIAL COMPLEX | 2011 |
|
RU2485183C1 |
METHOD OF TREATING UROGENITAL CANDIDIASIS USING ULTRASONIC CAVITATION AND PHOTOCHROMOTHERAPY | 2019 |
|
RU2704470C1 |
ANTIBACTERIAL AGENT IN FORM OF GEL BASED ON GENTAMYCIN AND 2(5H)-FURANONE DERIVATIVE | 2021 |
|
RU2765470C1 |
METHOD FOR TREATING RECURRENT FORMS OF FEMALE UROGENITAL CANDIDIASIS | 1999 |
|
RU2147434C1 |
METHOD FOR ANALYZING THE GRAVITY OF CANDIDIASIS | 0 |
|
SU1483374A1 |
METHOD FOR TREATING VAGINAL CANDIDIASIS | 2001 |
|
RU2197255C1 |
Authors
Dates
2025-06-02—Published
2024-12-17—Filed